Kluge A, Stroh H, Wagner D, Rauber K
Abteilung für Diagnostische Radiologie, Klinik, Justus-Liebig-Universität Giessen.
Rofo. 1998 Jul;169(1):63-7. doi: 10.1055/s-2007-1015051.
Evaluation of technical success rate, long-term outcome and initial complication rate in patients with fluoroscopically guided port implantation.
Between January 1994 and April 1997 124 ports were implanted under fluoroscopic guidance in 120 patients. Indications for port implantation were anti-cancer chemotherapy, antibiotic and supportive therapy in patients with tumours or cachexia.
Implantation was technically successful in 98.4% of the patients. We had a 3.2% minor complication rate that did not necessitate further treatment. One pneumothorax required a chest tube (0.8%). During a total of 17,534 days, complications occurred in 10.8% of all ports, 6.9% of the ports had to be explanted because of these complications.
Insertion of ports under fluoroscopic guidance has a low complication rate and good long-term results. The rate of 93.1% of functioning ports is superior to that reported in other studies. It is less costly and has a lower complication rate than surgical implantation. Therefore it seems to be the method of choice for patients requiring long-term subcutaneous venous access for chemotherapy or supportive therapy in malignant tumours or other emaciating diseases.
评估在透视引导下进行端口植入患者的技术成功率、长期疗效及初始并发症发生率。
1994年1月至1997年4月期间,在透视引导下为120例患者植入了124个端口。端口植入的适应证为肿瘤患者或恶病质患者的抗癌化疗、抗生素治疗及支持治疗。
98.4%的患者植入技术成功。轻微并发症发生率为3.2%,无需进一步治疗。1例气胸需要放置胸腔引流管(0.8%)。在总共17534天的时间里,所有端口中有10.8%发生并发症,其中6.9%的端口因这些并发症而不得不取出。
透视引导下端口植入并发症发生率低,长期效果良好。93.1%的端口功能良好率高于其他研究报道。与手术植入相比,其成本更低,并发症发生率更低。因此,对于恶性肿瘤或其他消耗性疾病需要长期皮下静脉通路进行化疗或支持治疗的患者,它似乎是首选方法。